Search clinical trials for: Levetiracetam, Keppra

Total 165 results

Duke University
UCB Pharma

Completed

Levetiracetam in Post-Traumatic Stress Disorder (PTSD)

Post-Traumatic Stress Disorder

United States
Assistance Publique - Hôpitaux de Paris

Completed

Study of Antiepileptic Drug in Generalised Convulsive Status Epilepticus (SAMU-KEPPRA)

Status; Epilepticus, Tonic-clonic

France
University of Cincinnati
Mayfield Clinic & Spine Institute

Completed

Assess Safety and Efficacy of Levetiracetam(LEV;Keppra)for Seizure Prevention (Keppra)

Traumatic Brain Injury | Subarachnoid Hemorrhage

United States
UCB Pharma
Parexel

Completed

Pharmacokinetic (PK) Study in Japanese Non-epileptic Renal Impaired Patients

Healthy Subjects | Renal Impairments

Japan
Emory University
UCB Pharma

Completed

IV Keppra in the Emergency Department for Prevention of Early Recurrent Seizures

Tonic-clonic Seizure

United States
UCB Pharma

Completed

Safety and Tolerability of Levetiracetam Intravenous 15 Minute Infusion in Subjects Suffering From Partial Onset Seizures

Epilepsy
UCB Pharma

Completed

Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia

Dyskinesia, Medication-induced

Belgium, Bulgaria
UCB Pharma

Completed

Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

Idiopathic Parkinson Disease
UCB Pharma

Completed

Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POS

Epilepsy, Partial
UCB Pharma

Completed

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

Epilepsy, Partial
UCB Pharma

Completed

A 16 Week Study Evaluating Levetiracetam in the Treatment of Post Herpetic Neuralgia (PHN)

Neuralgia, Postherpetic
UCB Pharma

Completed

Study on Safety and Efficacy of Levetiracetam in the Adjunctive Treatment of Female Subjects With C1 Catamenial Epilepsy

Epilepsy
UCB Pharma

Completed

Study to Assess the Efficacy and Safety of Levetiracetam for the Treatment of Social Anxiety Disorder (Generalized Type)

Anxiety Disorders
UCB Pharma

Completed

Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

Generalized Epilepsy
UCB Pharma

Completed

Study to Evaluate the Safety and Efficacy of Levetiracetam in Patients Suffering From Idiopathic Generalized Epilepsy With Primary Generalized Tonic-clonic Seizures

Generalized Convulsive Epilepsy
UCB Pharma

Completed

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

Epilepsy, Tonic-clonic
UCB Pharma

Completed

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy
UCB Pharma

Completed

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

Epilepsy
UCB Pharma

Completed

Pharmacokinetic Study of Levetiracetam in Epileptic Pediatric Subjects Ranging in Age From 1 Month to Less Than 4 Years Old

Epilepsy
UCB Pharma

Completed

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy
UCB Pharma

Completed

Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy

Epilepsy, Partial
UCB Pharma
UCB Japan Co. Ltd.

Completed

Bridging Study of L059 (Levetiracetam) in Patients With Epilepsy by Double Blind Method

Epilepsy
UCB Pharma

Completed

Levetiracetam as add-on Treatment of Myoclonic Jerks in Adolescents + Adults

Generalized Convulsive Epilepsy
UCB Pharma

Completed

A Safety and Efficacy Follow-up Study With Levetiracetam in Children (4-17 Years Old) Suffering From Absence Seizures

Absence Seizures
Duke University
UCB Pharma

Completed

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Motor Neuron Disease | Amyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Progressive Muscular Atrophy

United States
University of California, San Francisco
UCB Pharma

Completed

Levetiracetam for Treatment of Pain Associated With Fibromyalgia

Fibromyalgia

United States
Stephanie Merhar, MD

Terminated

Efficacy of Keppra for Neonatal Seizures

Neonatal Seizures

United States
Duke University
UCB Pharma

Terminated

Augmentation Study of Levetiracetam in Obsessive Compulsive Disorder

Obsessive-Compulsive Disorder

United States
UCB Japan Co. Ltd.

Completed

Multiple-dose Study of Levetiracetam Injection in Japanese and Caucasian Healthy Males

Healthy Volunteers

Japan
UCB Japan Co. Ltd.

Completed

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

Epilepsy | Partial Onset Seizures

Japan
UCB Pharma

Completed

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

Epilepsy, Partial

United States, France, United Kingdom, Germany, Belgium, Mexico, Poland, India, Romania, South Africa, Canada, Brazil, Russian Federation, Czech Republic, Hungary, Italy
GlaxoSmithKline

Completed

Clinical and Economic Burden of Uncontrolled Epilepsy: Analyses From a Medicaid Database and a Private Health Plan Database

Epilepsy
UCB Pharma

Completed

An Open-label, Bioequivalence Study to Evaluate LEV Administered as a 45-min Intravenous Infusion and Same Dosage LEV Oral Tablet in Chinese

Human Volunteers

China
UCB Pharma

Completed

A Randomized, Double-blind, Pharmacokinetics Study to Assess Safety, Tolerability of Levetiracetam 45 Minutes Intravenous Infusion During 4 Days of Bid Dosing in Chinese Healthy Volunteers

Human Volunteers

China
Rennes University Hospital
UCB Pharma

Terminated

Prevention of Post-traumatic Seizures With Levetiracetam (TRACK)

Epilepsy, Post-Traumatic

France
UCB Pharma

Completed

Efficacy and Safety of Levetiracetam in Routine Clinical Practice in Czech and Slovak Republics, Hungary, and Romania.

Epilepsy
UCB Pharma

Completed

Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam

Epilepsy

Spain
UCB Pharma

Completed

Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)

Healthy

United Kingdom
The Epilepsy Study Consortium
GlaxoSmithKline; The Epilepsy Research Foundation

Completed

Photosensitivity Proof of Concept Trial

Photosensitive Epilepsy

United States
Lindner Center of HOPE
UCB Pharma; University of Cincinnati

Completed

Levetiracetam Treatment of Panic Disorder and Lactate-Induced Panic Attacks

Panic Disorder

United States
UCB Pharma

Completed

Bioequivalence Study of Levetiracetam Tablet and Intravenous Infusion in Healthy Japanese Subjects

Healthy Volunteers

United Kingdom
Harvey S. Singer
UCB Pharma

Completed

Comparison of Keppra and Clonidine in the Treatment of Tics

Tourette Syndrome | Tic Disorders

United States
UCB Pharma

Completed

Open-label Study of Levetiracetam Intravenous Infusion in Children (4-16 Years Old) With Epilepsy

Epilepsy

France, United States, Belgium, Mexico, Turkey, Germany
Thomas Jefferson University
UCB Pharma

Completed

A Clinical Study Examining the Safety and Effectiveness of a New Medication (Keppra®) for the Prevention of Migraine Headaches

Migraine

United States
University of Texas Southwestern Medical Center
UCB Pharma

Completed

Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study

Memory Loss Associated With Corticosteroid Use | Manic State Associated With Corticosteroid Use

United States
The Cleveland Clinic
UCB Pharma

Completed

A Pilot Study of Efficacy and Tolerability of Levetiracetam Monotherapy in Subjects With Childhood Absence Epilepsy

Epilepsy | Seizures | Childhood Absence Epilepsy

United States
Charite University, Berlin, Germany
UCB Pharma

Completed

Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients (Keppra-2)

Alcohol Dependence | Alcoholic Relapse

Germany
Children's Hospital Medical Center, Cincinnati

Completed

Pharmacokinetics of Levetiracetam (Keppra) in Neonates

Epilepsy | Seizures

United States
Dr. Reddy's Laboratories Limited

Completed

Bioavailability Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fasting Conditions.

Healthy

United States
Dr. Reddy's Laboratories Limited

Completed

Bioequivalence Study of Levetiracetam Tablets, 750 mg of Dr. Reddy's Under Fed Conditions

Healthy

United States

3

Subscribe